Loading…

S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-06, Vol.6, p.198-199
Main Authors: Wilson, M., Castaman, G., Escolar, G., Miesbach, W., Santos, S., Yan, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 199
container_issue
container_start_page 198
container_title HemaSphere
container_volume 6
creator Wilson, M.
Castaman, G.
Escolar, G.
Miesbach, W.
Santos, S.
Yan, S.
description
doi_str_mv 10.1097/01.HS9.0000844080.44496.20
format article
fullrecord <record><control><sourceid>wiley_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4ad7a8df634a48d4bae19defcac7ca76</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4ad7a8df634a48d4bae19defcac7ca76</doaj_id><sourcerecordid>HEM3BF03554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2748-78d591d468e80dd8e398c28cb42ffe54bb691060f0e7ce78d5c8b40bd930099a3</originalsourceid><addsrcrecordid>eNqVkcFu1DAQhiMEElXpO1jcE8aOE9u9pamziZQm1ToUOFmO7bBbgoKSRVVvPALPyJOQ7VbAlbnMaGb-fzT6guAthgiDYO8AR6USEazBKQUOEaVUpBGBF8EZSRgJBaH45T_16-BiWe7XfSyESAk7C3aKCHaJMqWkUlWzQV0pUd6q7tePn7IoZN5Vd7JZZ6gtUN02m7Xfye0Nut22t-WnOvtYKaS6bdbJTSUVqhp01zboQ1XX8mqbNdfoulIyU_JN8Gow4-IvnvN58L6QXV6Gdbup8qwOLWGUh4y7RGBHU-45OMd9LLgl3PaUDINPaN-nAkMKA3hm_XHb8p5C70QMIISJz4Pq5Osmc6-_zfuvZn7Uk9nrp8Y0f9ZmPuzt6DU1jhnuhjSmhnJHe-OxcH6wxjJrWLp6XZ687Dwty-yHP34Y9BGBBqxXBPovAv2EQBNYxfQkfpjGg5-XL-P3Bz_rnTfjYaeBAKYUi5AAIes_EIdHKnyV5c-y_egf_-OgLuVNfFVAnCQ0_g2W2pat</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>PubMed Central</source><creator>Wilson, M. ; Castaman, G. ; Escolar, G. ; Miesbach, W. ; Santos, S. ; Yan, S.</creator><creatorcontrib>Wilson, M. ; Castaman, G. ; Escolar, G. ; Miesbach, W. ; Santos, S. ; Yan, S.</creatorcontrib><identifier>ISSN: 2572-9241</identifier><identifier>EISSN: 2572-9241</identifier><identifier>DOI: 10.1097/01.HS9.0000844080.44496.20</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott Williams &amp; Wilkins</publisher><ispartof>HemaSphere, 2022-06, Vol.6, p.198-199</ispartof><rights>Copyright © 2022 The Author(s).</rights><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1097%2F01.HS9.0000844080.44496.20$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1097%2F01.HS9.0000844080.44496.20$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,11562,27924,27925,46052,46476</link.rule.ids></links><search><creatorcontrib>Wilson, M.</creatorcontrib><creatorcontrib>Castaman, G.</creatorcontrib><creatorcontrib>Escolar, G.</creatorcontrib><creatorcontrib>Miesbach, W.</creatorcontrib><creatorcontrib>Santos, S.</creatorcontrib><creatorcontrib>Yan, S.</creatorcontrib><title>S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE</title><title>HemaSphere</title><issn>2572-9241</issn><issn>2572-9241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqVkcFu1DAQhiMEElXpO1jcE8aOE9u9pamziZQm1ToUOFmO7bBbgoKSRVVvPALPyJOQ7VbAlbnMaGb-fzT6guAthgiDYO8AR6USEazBKQUOEaVUpBGBF8EZSRgJBaH45T_16-BiWe7XfSyESAk7C3aKCHaJMqWkUlWzQV0pUd6q7tePn7IoZN5Vd7JZZ6gtUN02m7Xfye0Nut22t-WnOvtYKaS6bdbJTSUVqhp01zboQ1XX8mqbNdfoulIyU_JN8Gow4-IvnvN58L6QXV6Gdbup8qwOLWGUh4y7RGBHU-45OMd9LLgl3PaUDINPaN-nAkMKA3hm_XHb8p5C70QMIISJz4Pq5Osmc6-_zfuvZn7Uk9nrp8Y0f9ZmPuzt6DU1jhnuhjSmhnJHe-OxcH6wxjJrWLp6XZ687Dwty-yHP34Y9BGBBqxXBPovAv2EQBNYxfQkfpjGg5-XL-P3Bz_rnTfjYaeBAKYUi5AAIes_EIdHKnyV5c-y_egf_-OgLuVNfFVAnCQ0_g2W2pat</recordid><startdate>20220623</startdate><enddate>20220623</enddate><creator>Wilson, M.</creator><creator>Castaman, G.</creator><creator>Escolar, G.</creator><creator>Miesbach, W.</creator><creator>Santos, S.</creator><creator>Yan, S.</creator><general>Lippincott Williams &amp; Wilkins</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20220623</creationdate><title>S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE</title><author>Wilson, M. ; Castaman, G. ; Escolar, G. ; Miesbach, W. ; Santos, S. ; Yan, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2748-78d591d468e80dd8e398c28cb42ffe54bb691060f0e7ce78d5c8b40bd930099a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, M.</creatorcontrib><creatorcontrib>Castaman, G.</creatorcontrib><creatorcontrib>Escolar, G.</creatorcontrib><creatorcontrib>Miesbach, W.</creatorcontrib><creatorcontrib>Santos, S.</creatorcontrib><creatorcontrib>Yan, S.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Free Archive</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>HemaSphere</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, M.</au><au>Castaman, G.</au><au>Escolar, G.</au><au>Miesbach, W.</au><au>Santos, S.</au><au>Yan, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE</atitle><jtitle>HemaSphere</jtitle><date>2022-06-23</date><risdate>2022</risdate><volume>6</volume><spage>198</spage><epage>199</epage><pages>198-199</pages><issn>2572-9241</issn><eissn>2572-9241</eissn><cop>Philadelphia, PA</cop><pub>Lippincott Williams &amp; Wilkins</pub><doi>10.1097/01.HS9.0000844080.44496.20</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2572-9241
ispartof HemaSphere, 2022-06, Vol.6, p.198-199
issn 2572-9241
2572-9241
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4ad7a8df634a48d4bae19defcac7ca76
source Open Access: Wiley-Blackwell Open Access Journals; PubMed Central
title S297: ASSESSING THE COST‐EFFECTIVENESS OF LONG‐TERM PROPHYLAXIS STRATEGIES IN VON WILLEBRAND DISEASE
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A35%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=S297:%20ASSESSING%20THE%20COST%E2%80%90EFFECTIVENESS%20OF%20LONG%E2%80%90TERM%20PROPHYLAXIS%20STRATEGIES%20IN%20VON%20WILLEBRAND%20DISEASE&rft.jtitle=HemaSphere&rft.au=Wilson,%20M.&rft.date=2022-06-23&rft.volume=6&rft.spage=198&rft.epage=199&rft.pages=198-199&rft.issn=2572-9241&rft.eissn=2572-9241&rft_id=info:doi/10.1097/01.HS9.0000844080.44496.20&rft_dat=%3Cwiley_doaj_%3EHEM3BF03554%3C/wiley_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2748-78d591d468e80dd8e398c28cb42ffe54bb691060f0e7ce78d5c8b40bd930099a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true